Follow the entities shaping the evidence.

…nts who received more lines of systemic therapy (p=0.08). Serum GDF-15 levels correlated with higher IFN-γ (β = 0.49, p = 0.011), IL-1…

…sity, there was greater number of unique IgM clones expanded in Tras PH1 arm (p<0.05). D. Increased diversity of IgG1 and IgG2 chains we…

…patients (–1.21 kPa [95% CI: -2.00, -0.42]) (table 1). Adherent COPD patients experienced an improved PaO2 (+1.04 kPa [95% CI: 0.40,…

…ianakas A, Herzog S, Landmann A, et al. Successful treatment of discoid lupus erythematosus with fumaric acid esters. J Am Acad Dermatol. 2014;71(1):e15–7.…

…lymphoma, from 1999 onwards they started treating patients with rheumatoid arthritis with this B-cell depleting agent. Its effectiveness was obvious…

…ses could probe specific questions related to whether timing of diabetes onset matters and other ways in which cumulative measures captu…

…s] were evaluated ( table 1). The most common malignancies were breast cancer (n=134/566, 24%), colorectal cancer (n=66/566, 12%), and leukem…

…24). Epilepsy group was defined as ICD-10 G40, ICD-10 R56.9, or levetiracetam exposure. In a reciprocal analysis, adults meeting the epilepsy…

…Vedolizumab and Ustekinumab were first approved by our trust for treatment of patients with…

…d metabolism disorder, 1 (3%) with tyrosinemia, and 1 (3%) with dystonic cerebral palsy. Nine patients (25%) had normal carnitine levels despite long-t…

… TRIM69 inhibits cell proliferation and promotes ferroptosis in CRC cells by regulating the ASK1/MAPK signaling pathway). Furthermo…

…ant (FNET) and palonosetron (PAL). Prior to administration, the Akynzeo concentrate (20 mL vial) is diluted with 30 mL 0.9% sodium chlo…